Crucial US Advisory Committee to Decide on Altering Baby Hepatitis B Vaccine Recommendation
Following a hold-up and a particularly heated session, a national immunization advisory committee was set to cast ballots on Friday on whether to change the longstanding recommendation that each baby be immunized against hepatitis B.
Heated Debate and a Delayed Ballot
The first day of the meeting on Thursday was defined by intense argument over curbing eligibility to the hepatitis B vaccine for newborns and a resolution to defer the vote by a day to allow panelists additional time to examine the language. The committee, which advises the national health agency on immunization practices, had twice before postponed.
“Is there any definitive data of damage of giving this immunization before 30 days? Or is this speculation?” asked one panel member.
In reply, another participant stated, “There is scant proof about the long-term risk.”
Existing Recommendations and Possible Consequences
The injection is currently suggested for each baby within 24 hours of being born to stop transmission of hepatitis B, which can cause serious liver damage. It has been administered to more than a billion persons for more than three decades.
The Georgia assembly provided no recent proof of injuries resulting from the vaccine. Specialists note any modification to the present hepatitis B vaccine regimen could have major and extensive consequences for childhood health in the United States.
Committee Makeup and Latest Shifts
The consultative group can only offer guidance to the director of the CDC. The panel's membership has experienced alterations recently, with the announcement that the panel's latest chairman would step down for an official role and be succeeded by a heart specialist who has been questioning of other immunizations.
The panel includes multiple immunization doubters who are in agreement with a desire to overhaul – and possibly, in some cases, eliminate – long-established immunization guidelines.
